Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study

BACKGROUND: Concerns have been raised about the reduced immunogenicity of vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory diseases and the higher risk of breakthrough infections. The objective of our study was to investigate the intensity and longevity of SARS-CoV-2 vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, David, Tascilar, Koray, Fagni, Filippo, Kleyer, Arnd, Krönke, Gerhard, Meder, Christine, Dietrich, Peter, Orlemann, Till, Mößner, Johanna, Taubmann, Jule, Mutlu, Melek Yalcin, Knitza, Johannes, Kemenes, Stephan, Liphardt, Anna-Maria, Schönau, Verena, Bohr, Daniela, Schuster, Louis, Hartmann, Fabian, Minopoulou, Ioanna, Leppkes, Moritz, Ramming, Andreas, Pachowsky, Milena, Schuch, Florian, Ronneberger, Monika, Kleinert, Stefan, Hueber, Axel J, Manger, Karin, Manger, Bernhard, Atreya, Raja, Berking, Carola, Sticherling, Michael, Neurath, Markus F, Schett, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363042/
https://www.ncbi.nlm.nih.gov/pubmed/35966645
http://dx.doi.org/10.1016/S2665-9913(22)00191-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363042/
https://www.ncbi.nlm.nih.gov/pubmed/35966645
http://dx.doi.org/10.1016/S2665-9913(22)00191-6

Ejemplares similares